As Reported

Adjustment

As Restated

Balance Sheet as of March 31, 2021

Common stocks subject to possible redemption

$

251,956,520

$

24,043,480

$

276,000,000

Class A Common stocks, $0.0001 par value

252

(252)

0

Class B Common stocks, $0.0001 par value

690

0

690

Additional Paid in Capital

(1,304,287)

1,304,287

0

Accumulated Deficit

4,999,059

(23,843,226)

(18,844,167)

Total Stockholders’ Equity (Deficit)

$

5,000,001

$

(23,843,478)

$

(18,843,477)

Number of Class A common stock subject to redemption

25,215,652

2,384,348

27,600,000

Statement of Operations for the three months ended March 31, 2021

Weighted average shares outstanding, Class A common stocks basic and diluted

27,600,000

(12,573,333)

15,026,667

Weighted average shares outstanding, Class B common stocks basic and diluted

6,900,000

0

6,900,000

Basic and diluted net income per share, Class A common stock subject to possible redemption

$

0

$

0.29

$

0.29

Basic and diluted net loss per share, Class B common stock

$

0.92

$

(0.63)

$

0.29

Statement of Changes in Stockholders' Equity (Deficit) for the three months ended March 31, 2021

Sale of 27,600,000 Units on February 11, 2021, net of warrant fair value

$

264,592,000

$

(264,592,000)

$

0

Excess cash over fair value for Private Placement Warrants

$

1,199,067

$

0

$

1,199,067

Subsequent remeasurement under ASC 480-10-S99 against additional paid-in capital and accumulated deficit

$

0

$

26,383,166

$

26,383,166

Condensed Statement of Cash Flows for the three months ended March 31, 2021 (unaudited)

Supplemental disclosure of cash flow information:

Initial value of Class A common stocks subject to possible redemption

$

245,211,820

$

30,788,180

$

276,000,000

Change in value of Class A common stocks subject to possible redemption

$

6,944,702

$

(6,944,702)

$

0